The reiteration of a Buy rating and maintenance of a $15 price target by HC Wainwright & Co. analyst Yi Chen indicates a positive outlook for Vaccitech's stock. This news is directly related to VACC and is important for investors as it reflects the analyst's confidence in the company's potential growth. The score of 1 suggests that the stock price is likely to go up in the short term.